Literature DB >> 29685761

Impact of an institutional change from routine to highly selective diversion of a low anastomosis after TME for rectal cancer.

R D Blok1, R Stam2, E Westerduin2, W A A Borstlap2, R Hompes2, W A Bemelman2, P J Tanis2.   

Abstract

INTRODUCTION: The need for routine diverting ileostomy following restorative total mesorectal excision (TME) is increasingly debated as the benefits might not outweigh the disadvantages. This study evaluated an institutional shift from routine (RD) to highly selective diversion (HSD) after TME surgery for rectal cancer.
MATERIALS AND METHODS: Patients having TME with primary anastomosis and HSD for low or mid rectal cancer between December 2014 and March 2017 were compared with a historical control group with RD in the preceding period since January 2011. HSD was introduced in conjunction with uptake of transanal TME.
RESULTS: In the RD group, 45/50 patients (90%) had a primary diverting stoma, and 3/40 patients (8%) in the HSD group. Anastomotic leakage occurred in 10 (20%) and three (8%) cases after a median follow-up of 36 and 19 months after RD and HSD, respectively. There was no postoperative mortality. An unintentional stoma beyond 1 year postoperative was present in six and two patients, respectively. One-year stoma-related readmission and reoperation rate (including reversal) after RD were 84% and 86%, respectively. Corresponding percentages were significantly lower after HSD (17% and 17%; P < 0.001). Total hospital stay within one year was median 11 days (IQR 8-19) versus 5 days (IQR 4-11), respectively (P < 0.001).
CONCLUSION: This single institutional comparative cohort study shows that highly selective defunctioning of a low anastomosis in rectal cancer patients did not adversely affect incidence or consequences of anastomotic leakage with a substantial decrease in 1-year readmission and reintervention rate, leading to an overall significantly reduced hospital stay.
Copyright © 2018 Elsevier Ltd, BASO ~ The Association for Cancer Surgery, and the European Society of Surgical Oncology. All rights reserved.

Entities:  

Keywords:  Anastomotic leakage; Diverting ileostomy; Rectal cancer; Stoma; Total mesorectal excision

Mesh:

Year:  2018        PMID: 29685761     DOI: 10.1016/j.ejso.2018.03.033

Source DB:  PubMed          Journal:  Eur J Surg Oncol        ISSN: 0748-7983            Impact factor:   4.424


  7 in total

Review 1.  Dealing with Complications of Colorectal Surgery Using the Transanal Approach-When and How?

Authors:  K Talboom; P J Tanis; W A Bemelman; R Hompes
Journal:  Clin Colon Rectal Surg       Date:  2022-02-28

2.  Endoscopic vacuum-assisted surgical closure (EVASC) of anastomotic defects after low anterior resection for rectal cancer; lessons learned.

Authors:  Kevin Talboom; Nynke G Greijdanus; Cyriel Y Ponsioen; Pieter J Tanis; Wilhelmus A Bemelman; Roel Hompes
Journal:  Surg Endosc       Date:  2022-05-09       Impact factor: 4.584

3.  Stoma reversal after intended restorative rectal cancer resection in Denmark: nationwide population-based study.

Authors:  J B Jørgensen; R Erichsen; B G Pedersen; S Laurberg; L H Iversen
Journal:  BJS Open       Date:  2020-10-06

Review 4.  Current Status of the Management of Stage I Rectal Cancer.

Authors:  Craig Howard Olson
Journal:  Curr Oncol Rep       Date:  2020-04-02       Impact factor: 5.075

5.  The effect of a diverting stoma on morbidity and risk of permanent stoma following anastomotic leakage after low anterior resection for rectal cancer: a nationwide cohort study.

Authors:  Nis Hallundbæk Schlesinger; Henry Smith
Journal:  Int J Colorectal Dis       Date:  2020-06-14       Impact factor: 2.571

6.  Effects of Neoadjuvant Radiotherapy on Postoperative Complications in Rectal Cancer: A Meta-Analysis.

Authors:  Jianguo Yang; Yajun Luo; Tingting Tian; Peng Dong; Zhongxue Fu
Journal:  J Oncol       Date:  2022-01-05       Impact factor: 4.375

7.  Stoma versus anastomosis after sphincter-sparing rectal cancer resection; the impact on health-related quality of life.

Authors:  Jelle P A Algie; Robert T van Kooten; Rob A E M Tollenaar; Michel W J M Wouters; Koen C M J Peeters; Jan Willem T Dekker
Journal:  Int J Colorectal Dis       Date:  2022-09-26       Impact factor: 2.796

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.